Kenji Kabashima

Prostaglandin D2 as a mediator of allergic asthma.

S. Narumiya, Y. Urade, A. Mizoguchi, 2000, Science.

Efficacy and safety of ustekinumab in Japanese patients with severe atopic dermatitis: a randomized, double‐blind, placebo‐controlled, phase II study

K. Kabashima, Y. Tokura, B. Randazzo, 2017, The British journal of dermatology.

Topical Treatment with Basic Fibroblast Growth Factor Promotes Wound Healing and Barrier Recovery Induced by Skin Abrasion

K. Kabashima, Y. Miyachi, S. Nakamizo, 2012, Skin Pharmacology and Physiology.

Fluctuation of circulating plasmacytoid dendritic cells in a patient with psoriatic arthritis

M. Ogata, R. Hino, K. Sugita, 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

This information is current as Immunosuppression Langerhans Cells in Local UVB-Induced OX 40 Ligand-Expressing Mature Producing and − The Mandatory Role of IL-10

T. Bito, K. Sugita, J. Sakabe, 2010 .

Flaky tail mouse denotes human atopic dermatitis in the steady state and by topical application with Dermatophagoides pteronyssinus extract.

T. Honda, M. Hara-Chikuma, A. Kubo, 2010, The American journal of pathology.

Expression of toll‐like receptor 2, NOD2 and dectin‐1 and stimulatory effects of their ligands and histamine in normal human keratinocytes

K. Kabashima, Y. Tokura, R. Yoshiki, 2009, The British journal of dermatology.